Executive Summary
The premise of this analytical assessment was to evaluate how Pfizer uses analytics as it relates to decision making. The assessment focuses on the organization as a whole, with interviews from two colleagues in two different business units: Development Operations (GIP) and the Business Analytics & Insight (GEP). Overall, it is evident that Pfizer, as a consequence of being a heavily regulated pharmaceutical industry, must use scientific data to ensure that the products we make are safe and effective. My assessment concluded that, as expected, there are many moving parts to getting a product out in the market and that Pfizer is using analytics as a competitive advantage. The assessment also concluded that there is room for …show more content…
When asked about the importance of analytics and how much Pfizer values Analytics, Deanna candidly replied "Pfizer respects analytics". She explained to me how her team works very closely with the Center Of Excellence (COE) at Pfizer to "develop governance of how data is used and managed". The groups work closely together to maximize the business by ensuring there is minimal impact to the business when a drug loses its patent. By forecasting LOE curves, the team is able to determine the best path forward; whether Pfizer pursues new opportunities by focusing on business development opportunities, single product opportunities, or licensing opportunities. , Business Analytics and Insights Director Deanna Schwartz …show more content…
The four pillars are highlighted below with examples of where Pfizer demonstrates each of them:
• Analytics supported a strategic, distinctive capability---seen throughout the organization, particularly with Sales Insight.
• The approach to and management of analytics was enterprise-wide---GIP/GEP/VOC1
• Senior management was committed to the use of analytics---Both examples above (PMAE and Sales Insight) stress how crucial senior management comment is in the application of analytics
• The company made a significant strategic bet on analytics-based competition---throughout the company, but in particular with the interaction between the Pfizer sales representatives and the doctors prescribing the drugs (Sales Insight example).
Stage of Analytical Competition
Although not every company can be at stage 5, when you 're one of the biggest pharmaceutical companies in the world, it is imperative that you strive to become an analytical competitor and make analytics your most precious competitive advantage. In my opinion, Pfizer is operating at a stage 5; not only do we have upper management involvement/sponsorship in analytics, but we have distinctive capabilities, use enterprise-wide analytics and have large scare ambition3. This has positioned Pfizer as one of the biggest pharmaceutical companies in the
The premise of this analytical assessment was to evaluate how Pfizer uses analytics as it relates to decision making. The assessment focuses on the organization as a whole, with interviews from two colleagues in two different business units: Development Operations (GIP) and the Business Analytics & Insight (GEP). Overall, it is evident that Pfizer, as a consequence of being a heavily regulated pharmaceutical industry, must use scientific data to ensure that the products we make are safe and effective. My assessment concluded that, as expected, there are many moving parts to getting a product out in the market and that Pfizer is using analytics as a competitive advantage. The assessment also concluded that there is room for …show more content…
When asked about the importance of analytics and how much Pfizer values Analytics, Deanna candidly replied "Pfizer respects analytics". She explained to me how her team works very closely with the Center Of Excellence (COE) at Pfizer to "develop governance of how data is used and managed". The groups work closely together to maximize the business by ensuring there is minimal impact to the business when a drug loses its patent. By forecasting LOE curves, the team is able to determine the best path forward; whether Pfizer pursues new opportunities by focusing on business development opportunities, single product opportunities, or licensing opportunities. , Business Analytics and Insights Director Deanna Schwartz …show more content…
The four pillars are highlighted below with examples of where Pfizer demonstrates each of them:
• Analytics supported a strategic, distinctive capability---seen throughout the organization, particularly with Sales Insight.
• The approach to and management of analytics was enterprise-wide---GIP/GEP/VOC1
• Senior management was committed to the use of analytics---Both examples above (PMAE and Sales Insight) stress how crucial senior management comment is in the application of analytics
• The company made a significant strategic bet on analytics-based competition---throughout the company, but in particular with the interaction between the Pfizer sales representatives and the doctors prescribing the drugs (Sales Insight example).
Stage of Analytical Competition
Although not every company can be at stage 5, when you 're one of the biggest pharmaceutical companies in the world, it is imperative that you strive to become an analytical competitor and make analytics your most precious competitive advantage. In my opinion, Pfizer is operating at a stage 5; not only do we have upper management involvement/sponsorship in analytics, but we have distinctive capabilities, use enterprise-wide analytics and have large scare ambition3. This has positioned Pfizer as one of the biggest pharmaceutical companies in the